119 related articles for article (PubMed ID: 37678027)
1. Crosstalk between PD-L1 and Jak2-Stat3/ MAPK-AP1 signaling promotes oral cancer progression, invasion and therapy resistance.
Jha A; Alam M; Kashyap T; Nath N; Kumari A; Pramanik KK; Nagini S; Mishra R
Int Immunopharmacol; 2023 Nov; 124(Pt A):110894. PubMed ID: 37678027
[TBL] [Abstract][Full Text] [Related]
2. Role and regulation of GLUT1/3 during oral cancer progression and therapy resistance.
Kumari A; Jha A; Tiwari A; Nath N; Kumar A; Nagini S; Mishra R
Arch Oral Biol; 2023 Jun; 150():105688. PubMed ID: 36989865
[TBL] [Abstract][Full Text] [Related]
3. Crosstalk between Raf-MEK-ERK and PI3K-Akt-GSK3β signaling networks promotes chemoresistance, invasion/migration and stemness via expression of CD44 variants (v4 and v6) in oral cancer.
Kashyap T; Pramanik KK; Nath N; Mishra P; Singh AK; Nagini S; Rana A; Mishra R
Oral Oncol; 2018 Nov; 86():234-243. PubMed ID: 30409306
[TBL] [Abstract][Full Text] [Related]
4. Bcl-xL expression and regulation in the progression, recurrence, and cisplatin resistance of oral cancer.
Alam M; Mishra R
Life Sci; 2021 Sep; 280():119705. PubMed ID: 34111459
[TBL] [Abstract][Full Text] [Related]
5. ERK-mediated upregulation of matrix metalloproteinase-2 promotes the invasiveness in human oral squamous cell carcinoma (OSCC).
Pramanik KK; Mishra R
Exp Cell Res; 2022 Feb; 411(1):112984. PubMed ID: 34951997
[TBL] [Abstract][Full Text] [Related]
6. Oral squamous cell carcinoma cell-derived GM-CSF regulates PD-L1 expression in tumor-associated macrophages through the JAK2/STAT3 signaling pathway.
Wang P; Tao L; Yu Y; Wang Q; Ye P; Sun Y; Zhou J
Am J Cancer Res; 2023; 13(2):589-601. PubMed ID: 36895967
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of ATM reverses EMT and decreases metastatic potential of cisplatin-resistant lung cancer cells through JAK/STAT3/PD-L1 pathway.
Shen M; Xu Z; Xu W; Jiang K; Zhang F; Ding Q; Xu Z; Chen Y
J Exp Clin Cancer Res; 2019 Apr; 38(1):149. PubMed ID: 30961670
[TBL] [Abstract][Full Text] [Related]
8. Curcumol inhibits the expression of programmed cell death-ligand 1 through crosstalk between hypoxia-inducible factor-1α and STAT3 (T705) signaling pathways in hepatic cancer.
Zuo HX; Jin Y; Wang Z; Li MY; Zhang ZH; Wang JY; Xing Y; Ri MH; Jin CH; Xu GH; Piao LX; Ma J; Jin X
J Ethnopharmacol; 2020 Jul; 257():112835. PubMed ID: 32278762
[TBL] [Abstract][Full Text] [Related]
9. All-trans retinoic acid induces anti-tumor effects via STAT3 signaling inhibition in oral squamous cell carcinoma and oral dysplasia.
Chen XJ; He MJ; Zhou G
J Oral Pathol Med; 2019 Oct; 48(9):832-839. PubMed ID: 31323146
[TBL] [Abstract][Full Text] [Related]
10. JAK2 regulation by licochalcone H inhibits the cell growth and induces apoptosis in oral squamous cell carcinoma.
Oh HN; Oh KB; Lee MH; Seo JH; Kim E; Yoon G; Cho SS; Cho YS; Choi HW; Chae JI; Shim JH
Phytomedicine; 2019 Jan; 52():60-69. PubMed ID: 30599913
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin-induced programmed cell death ligand-2 expression is associated with metastasis ability in oral squamous cell carcinoma.
Sudo S; Kajiya H; Okano S; Sasaki M; Katsumata Y; Ohno J; Ikebe T; Hiraki A; Okabe K
Cancer Sci; 2020 Apr; 111(4):1113-1123. PubMed ID: 32012401
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-6 mediated inflammasome activation promotes oral squamous cell carcinoma progression via JAK2/STAT3/Sox4/NLRP3 signaling pathway.
Xiao L; Li X; Cao P; Fei W; Zhou H; Tang N; Liu Y
J Exp Clin Cancer Res; 2022 May; 41(1):166. PubMed ID: 35513871
[TBL] [Abstract][Full Text] [Related]
13. IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma.
Zhang W; Liu Y; Yan Z; Yang H; Sun W; Yao Y; Chen Y; Jiang R
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581055
[TBL] [Abstract][Full Text] [Related]
14. Atezolizumab and blockade of LncRNA PVT1 attenuate cisplatin resistant ovarian cancer cells progression synergistically via JAK2/STAT3/PD-L1 pathway.
Chen Y; Li F; Li D; Liu W; Zhang L
Clin Immunol; 2021 Jun; 227():108728. PubMed ID: 33878452
[TBL] [Abstract][Full Text] [Related]
15. Convallatoxin promotes apoptosis and inhibits proliferation and angiogenesis through crosstalk between JAK2/STAT3 (T705) and mTOR/STAT3 (S727) signaling pathways in colorectal cancer.
Zhang ZH; Li MY; Wang Z; Zuo HX; Wang JY; Xing Y; Jin C; Xu G; Piao L; Piao H; Ma J; Jin X
Phytomedicine; 2020 Mar; 68():153172. PubMed ID: 32004989
[TBL] [Abstract][Full Text] [Related]
16. CCL18-NIR1 promotes oral cancer cell growth and metastasis by activating the JAK2/STAT3 signaling pathway.
Jiang X; Huang Z; Sun X; Zheng X; Liu J; Shen J; Jia B; Luo H; Mai Z; Chen G; Zhao J
BMC Cancer; 2020 Jul; 20(1):632. PubMed ID: 32641093
[TBL] [Abstract][Full Text] [Related]
17. Effect of baricitinib in regulating programmed death 1 and ligand programmed cell death ligand 1 through JAK/STAT pathway in psoriasis.
Deepak HB; Prince SE; Deshpande P
Indian J Pharmacol; 2022; 54(3):183-193. PubMed ID: 35848689
[TBL] [Abstract][Full Text] [Related]
18. Orexin A Suppresses the Expression of Exosomal PD-L1 in Colon Cancer and Promotes T Cell Activity by Inhibiting JAK2/STAT3 Signaling Pathway.
Wen J; Chang X; Bai B; Gao Q; Zhao Y
Dig Dis Sci; 2022 Jun; 67(6):2173-2181. PubMed ID: 34097168
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-375 reverses the expression of PD-L1 by inactivating the JAK2/STAT3 signaling pathways in gastric cancer.
Yan XL; Luo QY; Zhou SN; Pan WT; Zhang L; Yang DJ; Qiu MZ
Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101574. PubMed ID: 33272890
[TBL] [Abstract][Full Text] [Related]
20. Galangin inhibits programmed cell death-ligand 1 expression by suppressing STAT3 and MYC and enhances T cell tumor-killing activity.
Zhong Y; Li MY; Han L; Tai Y; Cao S; Li J; Zhao H; Wang R; Lv B; Shan Z; Zuo HX; Piao L; Jin HL; Xing Y; Jin X; Ma J
Phytomedicine; 2023 Jul; 116():154877. PubMed ID: 37267692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
